| Literature DB >> 35226418 |
In Hyuk Yoo1, Hyun Mi Kang1, Dae Chul Jeong2.
Abstract
BACKGROUND: Intussusception refers to the invagination of a part of the intestine into itself. The exact cause for this condition is unknown in most cases. The active implementation of coronavirus disease 2019 (COVID-19) infection control guidelines has reduced the spread of COVID-19 and the incidence of other infectious diseases in children. The current study aimed to identify changes in pediatric intussusception and infectious diseases after the implementation of infection control guidelines and confirm the association between intussusception and contagious diseases.Entities:
Keywords: COVID-19; Intussusception; Viral infection, Social Distancing, Incidence Rate
Mesh:
Year: 2022 PMID: 35226418 PMCID: PMC8885455 DOI: 10.3346/jkms.2022.37.e60
Source DB: PubMed Journal: J Korean Med Sci ISSN: 1011-8934 Impact factor: 2.153
Comparison of the monthly incidence of emergency pediatric diseases before and after COVID-19 in seven hospitals
| Diseases | Pre-COVID-19 period | COVID-19 period | |
|---|---|---|---|
| Intussusception | 9.0 (6.0–11.0) | 3.5 (2.0–5.0) | < 0.001 |
| Anaphylaxis | 6.0 (4.0–8.0) | 5.5 (5.0–7.0) | 0.547 |
| Syncope | 28.0 (20.0–37.0) | 32.5 (23.0–41.0) | 0.493 |
Data are presented as median (interquartile range).
COVID-19 = coronavirus disease 2019.
Comparison of the monthly incidence of infectious diseases before and after COVID-19; confirmed as per the open data obtained from the Korea Disease Control and Prevention Agency
| Diseases | Pre-COVID-19 period | COVID-19 period | |
|---|---|---|---|
| Respiratory viruses | 7,979.0 ± 3,850.8 | 815.2 ± 309.4 | < 0.001 |
| Enteroviruses | 262.2 ± 353.6 | 6.6 ± 3.8 | < 0.001 |
| Viral gastroenteritis | 916.2 ± 495.7 | 197.8 ± 105.2 | < 0.001 |
| Bacterial gastroenteritis | 686.3 ± 334.0 | 776.3 ± 407.4 | 0.542 |
Data are presented as mean ± standard deviation.
COVID-19 = coronavirus disease 2019.
Fig. 1Interrupted time series regression analysis of monthly cases by diseases. Horizontal lines depict interventions. The significance of intervention is shown in the center of the lines. (A) Intussusception. (B) Respiratory viruses. (C) Enteroviruses. (D) Viral enteritis.
Interrupted time series regression analysis of monthly cases by diseases
| Diseases | Change in intercept | Change in slope | ||||
|---|---|---|---|---|---|---|
| Coefficient | Standard error | Coefficient | Standard error | |||
| Intussusception | −5.01 | 2.95 | 0.096 | −0.34 | 0.43 | 0.440 |
| Respiratory viruses | −7,748.74 | 2,405.84 | 0.002 | −226.22 | 365.76 | 0.540 |
| Enteroviruses | −452.4 | 186.73 | 0.020 | −4.8 | 29.31 | 0.871 |
| Viral enteritis | −621.69 | 341.94 | 0.076 | −8.27 | 56.19 | 0.884 |
Comparison of clinical characteristics of patients with intussusception before and after COVID-19
| Variables | Pre-COVID-19 period (n = 346) | COVID-19 period (n = 44) | |||
|---|---|---|---|---|---|
| Age at the time of diagnosis, mon | 24 (15.0–35.0) | 18.5 (10.5–31.8) | 0.100 | ||
| Male | 245 (70.8) | 30 (68.2) | 0.719 | ||
| The methods of reduction | 0.211 | ||||
| Non-operative reduction | 324 (93.6) | 39 (88.6) | |||
| Operation | 22 (6.4) | 5 (11.4) | |||
| Intussusception type | 1.000 | ||||
| Ileocolic type | 16 (28.6) | 6 (31.6) | |||
| Ileoileal type or colocolic type | 7 (2.0) | 1 (2.3) | |||
| Clinical symptom | |||||
| Abdominal pain or irritability | 303 (87.6) | 37 (84.1) | 0.515 | ||
| Vomiting | 115 (33.2) | 16 (36.4) | 0.679 | ||
| Bloody or currant jelly stool | 69 (19.9) | 18 (40.9) | 0.002 | ||
| Diarrhea | 30 (8.7) | 4 (9.1) | 0.926 | ||
| Fever | 42 (12.1) | 1 (2.3) | 0.049 | ||
| Upper respiratory symptoms | 28 (8.1) | 2 (4.5) | 0.556 | ||
| Past history of intussusception | 36 (10.4) | 6 (13.6) | 0.604 | ||
| Recurrent intussusception within 72 hr | 44 (12.7) | 6 (13.6) | 0.864 | ||
| Confirmation of leading points | 2 (0.6) | 1 (2.3) | 0.302 | ||
| Laboratory examination | |||||
| WBC | 10,995 (8,617–13,777) | 11,400 (10,060–14,340) | 0.149 | ||
| Eosinophil, % | 0.5 (0.1–1.3) | 0.3 (0.1–1.1) | 0.196 | ||
| Hb | 12.3 (11.7–12.8) | 12.4 (11.6–13.0) | 0.838 | ||
| Platelet | 305,500 (259,500–369,750) | 340,000 (302,000–425,000) | 0.011 | ||
| CRP | 0.3 (0.1–0.9) | 0.3 (0.1–1.0) | 0.606 | ||
| Glucose | 103 (91–116) | 102 (91–113) | 0.639 | ||
| Total protein | 6.7 (6.4–6.9) | 6.7 (6.4–7.0) | 0.229 | ||
| Albumin | 4.4 (4.2–4.6) | 4.5 (4.3–4.6) | 0.207 | ||
| AST | 36 (31–41) | 37 (32–40) | 0.255 | ||
| ALT | 15 (13–20) | 15 (12–21) | 0.647 | ||
| Sodium | 139 (137–140) | 138 (135–140) | 0.047 | ||
| Potassium | 4.3 (4.1–4.6) | 4.3 (4.2–4.6) | 0.585 | ||
| Chloride | 104 (103–106) | 104 (103–106) | 0.275 | ||
Data are presented as median (interquartile range) or number (%).
COVID-19 = coronavirus disease 2019, WBC = white blood cell, Hb = hemoglobin, CRP = C-reactive protein, AST = aspartate transaminase, ALT = alanine transaminase.